Covaxin production ramp-up may be delayed by 2 months; to reach 100 mn capacity by Nov msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Loading the player.
Apple announces first-ever $200 million carbon removal initiative
Cupertino giant Apple on Thursday, April 15, announced a first-of-its-kind carbon removal initiative called Restore Fund . Under this new initiative investments will be made in forestry projects to remove carbon from the atmosphere. The new initiative is part of Apple s broader goal of becoming carbon neutral across its entire value chain by 2
COVID-19 vaccine: Centre permits Mumbai s Haffkine Institute to produce Covaxin
The Centre has given its nod to Mumbai-based Haffkine Institute to manufacture Bharat Biotech s COVID-19 vaccine Covaxin. Technology transfer will take place from Bharat Biotech to Haffkine for manufacturing Covaxin. Haffkine has been given a time of 1 year for it
Mumbai-Based Haffkine Gets Centre s Nod To Produce Covaxin
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin. Outlook Web Bureau 2021-04-16T08:07:40+05:30 Mumbai-Based Haffkine Gets Centre s Nod To Produce Covaxin outlookindia.com 2021-04-16T09:21:52+05:30
Also read
The centre has given its permission to the Mumbai-based Haffkine Institute to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech, an official said on Thursday.
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin, which is currently produced by the Hyderabad-based Bharat Biotech, the official from the chief minister s office (CMO) said.
Express News Service
NEW DELHI: The Centre has now rushed to handhold Hyderabad-based Bharat Biotech in boosting the production of Covaxin, the country’s first and only indigenous Covid vaccine approved by the drug regulator, as a ferocious second wave of the pandemic has hit India hard.
After allowing Mumbai-based Haffkine Institute to produce Covaxin on a technology transfer basis following a plea by the Maharashtra government, the Union government has also decided to provide Rs 65 crore support to Bharat Biotech’s Bengaluru facility, said government sources.
Covaxin, apart from Covishield by the Serum Institute of India (SII), is the only available Covid vaccine in the country but its share has been fairly limited, only about 15% of about 11.75 crore doses administered, owing to its limited supply.